Publications for David F. Kronn david_kronn@nymc.edu
Bentler, K., Zhai, S., Elsbecker, S. A., Arnold, G. L., Burton, B. K., Vockley, J., . . Kronn, D. (2016). 221 newborn-screened neonates with medium-chain acyl-coenzyme A dehydrogenase deficiency: Findings from the inborn errors of metabolism collaborative. Molecular Genetics and Metabolism, 119(1-2), 75-82. doi:10.1016/j.ymgme.2016.07.002
Hahn, S., Pena, L., Day, J. W., Gambello, M., Gibson, J. B., Kronn, D., . . . Pompe ADVANCE Study Consortium. (2016). 52-week efficacy and safety profile of alglucosidase alfa produced at 4000 liter scale in US patients with Pompe disease: ADVANCE, a phase 4 open-label prospective study. Molecular Genetics and Metabolism, 117(2), S54. doi:10.1016/j.ymgme.2015.12.281
Kishnani, P. S., Day, J. W., Gambello, M., Gibson, J. B., Hillman, R., Kronn, D., . . . Pompe ADVANCE Study Consortium. (2016). Clinical characteristics and genotypes in the ADVANCE baseline dataset, a comprehensive cohort of US children and youth with pompe disease. Molecular Genetics and Metabolism, 117(2), S68. doi:10.1016/j.ymgme.2015.12.323
Kishnani, P. S., Hahn, S., Day, J. W., Gambello, M. J., Gibson, J. B., Kronn D., . . . Pompe ADVANCE Study Consortium. (2016). Infusion-associated reactions and immunogenicity in the advance study of alglucosidase alfa produced at 4000 L scale in patients with Pompe disease. Molecular Genetics and Metabolism, 117(3), 265. This material can be found here.
Kronn, D., Gottesdiener, L., Marrero-Stein, V., Stein, M., & Banikazemi, M. (2016). Infantile onset Pompe disease: Sibling cases in the pre-newborn screening era. Molecular Genetics and Metabolism, 117(3), 266-267. This material can be found here.
Mofidi, S., & Kronn, D. (2016). Recurrent infection induces apparent liver failure in a female with chrullinemia type 1. Molecular Genetics and Metabolism, 117(3), 272. This material can be found here.
Vogel, B. H., Bradley, S. E., Adams, D. J., D'Aco, K., Erbe, R. W., Fong, C., . . . Kronn, D. (2015). Newborn screening for X-linked adrenoleukodystrophy in New York State: Diagnostic protocol, surveillance protocol and treatment guidelines. Molecular Genetics and Metabolism, 114(4), 599-603. doi:10.1016/j.ymgme.2015.02.002